Abstract:Currently there is no reliable nomogram to predict the overall survival (OS) for patients with esophageal squamous cancer (ESCC) after chemoradiation therapy followed by surgery. The purpose of this study is to develop the above nomogram through the correlation of pretreatment clinical features that are commonly indicated for prognosis. We searched through Surveillance, Epidemiology, and End Results (SEER) database. A criterion for the search is listed as follows: (1) patients diagnosed with pathologically proved ESCC; (2) patients diagnosed in 2010-2014(AJCC 2010 7th version); (3) patients with T1-4N0-3M0 disease; (4) patients underwent chemoradiation therapy followed by surgery. Age, ethnicity, sex, Primary Site of the tumor, T stage, N stage were recorded as clinical predictors. These predictors were used in multivariable logistic regression analysis based nomograms to estimate the probabilities of OS. The predictive accuracy and discriminative ability of the nomogram were determined by concordance index (C-index) and calibration curve. Analyses were performed with open-source statistical software R (version 3.2.1). There were 5,508 patients with ESCC diagnosed in 2010-2014, 326 patients were identified. A total of 41% of patients were male. A total of 62% were aged 50 to 70.72% and were in the white race. Proportion of the patients diagnosed in T1, T2, T3, and T4 were 15%, 18%, 63%, and 4%; 92% of the patients were in N0-1 stage; 88.3% of the tumor were located in middle and lower third of esophagus; only 4% had overlapping lesion of esophagus. The 3-year and 4-year OS for the entire cohort of the patients were 53%, 47% with the median survival time of 45 months. Median survival of male and female patients were 38 months vs. 54 months (p=0.024); 3 year survival of patients with white race and other race were 56% vs. 45%, p=0.050; 3 year OS for patients with T1-2 and T3-4 stage were 60.8% vs. 52.4%, p = 0.198. For patients with N0, N1, N2, and N3 stage, 3-year OS were 87.3%, 54.3%, 37.1%, and 0%, p < 0.001. Primary site of the tumor was not the prognostic factors. Nomograms were developed for the predicted OS with age, sex, ethnicity, T stage, and N stage. The calibration curve for probabilities showed relatively good agreement between prediction by nomogram and actual observation. The C-index of the nomograms for predicting for predicting OS is 0.63. The risk of having one of the indications of adjuvant radiation therapy increased with increases in predictors except for clinical T stage. Using clinical information, we produced nomograms, which may relatively accurately predict the probabilities of overall survival for patients with esophageal squamous cancer after chemoradiation therapy followed by surgery. This nomogram may help individualize initial treatment options.

Nomograms for predicting the survival rate for cervical cancer patients who undergo radiation therapy: a SEER analysis.

Calculating the overall survival probability in patients with cervical cancer: a nomogram and decision curve analysis-based study

Prognostic Nomograms for Patients with Metastatic Gastric Cancer: A Large Population-Based Cohort Study and External Validation

Development and validation of a nomogram for predicting survival in gastric signet ring cell carcinoma patients treated with radiotherapy

Nomogram for Predicting Survival in Triple-Negative Breast Cancer Patients with Histology of Infiltrating Duct Carcinoma: a Population-Based Study.

Clinical Nomogram for Predicting Survival of Esophageal Cancer Patients after Esophagectomy

Constructing and Validating a Prognosis Predictive Nomogram for Cancer-Specific Survival in Rectal Cancer Patients Receiving Preoperative Radiotherapy.

Nomogram to Predict the Overall Survival for Patients Underwent Preoperative Radiation Therapy with Chemotherapy

Establishment of a prognostic nomogram based on the clinical and inflammatory parameters as well as acute radiation enteritis for patients with cervical cancer receiving radiotherapy

Development and validation of prognostic nomographs for patients with cervical cancer: SEER-based Asian population study

A Nomogram to Predict Prognosis of Patients with Unresected Hepatocellular Carcinoma Undergoing Radiotherapy: a Population-Based Study

Prognostic nomogram for predicting the overall survival rate of patients with uterine clear‐cell carcinoma: Based on SEER database

Nomogram to predict overall survival for patients with non-metastatic cervical esophageal cancer: a SEER-based population study

A Prognostic Nomogram for Cervical Cancer after Surgery from SEER Database.

A Reliable Nomogram is Identified to Predict the Overall Survival for Patients with Esophageal Squamous Cancer after Chemoradiation Therapy Followed by Surgery

Radiotherapy can improve overall survival in patients with lymph-node positive, high-grade neuroendocrine cervical cancer: construction of two prognostic nomograms to predict treatment outcome

CT-based radiomics nomogram for overall survival prediction in patients with cervical cancer treated with concurrent chemoradiotherapy

Development and Validation of a Nomogram for Predicting Survival in Patients with Testicular Germ Cell Tumors

Survival Nomogram for Patients with Initially Diagnosed Metastatic Non-Small-cell Lung Cancer: a SEER-based Study

Construction and Validation of a MRI‐Based Radiomic Nomogram to Predict Overall Survival in Patients with Local Advanced Cervical Cancer: A Multicenter Study

Nomograms for Predicting Specific Distant Metastatic Sites and Overall Survival of Colorectal Cancer Patients: A Large Population-Based Real-World Study.